/Investor DB

eGenesis, Inc. Full-time

operating company · company profile

New York · 2 people tracked

Find your way into eGenesis, Inc. Full-time

Sign up to see every warm intro you have to eGenesis, Inc. Full-time

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the eGenesis, Inc. Full-time team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

eGenesis is focused on using advanced multiplex gene editing and genome engineering to revolutionize the treatment of organ failure. The company aims to make cross-species transplantation viable, with the goal of ending waitlist mortality and removing organ supply as a barrier to transplant. It has built a porcine genome engineering platform that uses gene editing to create donor animals compatible with human transplantation, focusing on three classes of genetic edits to address retroviral risk and improve immunologic and molecular compatibility with human recipients.

Source: firm website, verified Nov 8, 2026.

HQ
New York, NY, US

Team · 2 people

from the firm's website & public directories
Mike Curtis· President, Chief Executive Officer and Director

Mike Curtis, Ph.D., serves as President, Chief Executive Officer, and Director of eGenesis.

Paul Sekhriin𝕏

Paul J. Sekhri is Chairman, President, and Chief Executive Officer of vTv Therapeutics, where he has overseen the company's restructuring and financing to advance a diabetes therapy into Phase III clinical trials. With nearly four decades of experience in pharmaceutical and biotechnology leadership, he has served as Director, Chairman, or Executive Chairman on more than 40 public and private company boards across the United States, Europe, and Israel, with expertise in board governance, capital formation, M&A, and business development. He holds degrees in Membrane Physiology and Zoology from the University of Maryland School of Medicine and is based across North America and Europe.

Frequently asked questions

What sectors does eGenesis, Inc. Full-time focus on?
eGenesis, Inc. Full-time focuses on Biotech, Deep Tech, Medical Devices.
Where is eGenesis, Inc. Full-time located?
eGenesis, Inc. Full-time is headquartered in New York, US.

Images

eGenesis, Inc. Full-time photo

Similar investors